|
English
|
正體中文
|
简体中文
|
2822924
|
|
???header.visitor??? :
30051288
???header.onlineuser??? :
1015
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"davies lucy claire"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
國立臺灣大學 |
2015 |
The impact on overall survival (OS) of first-line gefitinib (G) and erlotinib (E) and of clinical factors in advanced non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor mutations (EGFR mut) based on meta-analysis of 1,231 patients (pts) enrolled in 6 major randomized trials.
|
Lee, Chee; Davies, Lucy Claire; Wu, Yi-Long; Mitsudomi, Tetsuya; Inoue, Akira; Rosell, Rafael; Zhou, Caicun; Nakagawa, Kazuhiko; Throngprasert, Sumitra; Fukuoka, Masahiro; Gralla, Richard J.; Gebski, Val; Mok, Tony; Yang, James Chih-Hsin; 楊志新 |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|